- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise. Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.
The report details the trend, potential and market size of Gabapentin market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gabapentinmarket, defines the market attractiveness level of Gabapentin market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gabapentin industry, describes the types of Gabapentin market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gabapentin market and the development prospects and opportunities of Gabapentin industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gabapentin market in Chapter 13.
By Player:
Mylan
Alkem
Amneal
Marksans Pharma
Intas
Arbor Pharma
Apotex
Aurobindo Pharma
Jiangsu Enhua
Sun Pharmaceutical
Glenmark
TEVA
Sailike
Assertio Therapeutics
Jiangsu Hengrui
Novartis
By Type:
Capsule
Tablet
By End-User:
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gabapentin Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gabapentin Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gabapentin Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gabapentin Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gabapentin Market Analysis and Outlook to 2022
-
7.1 Global Gabapentin Consumption (2017-2022)
-
7.2 United States Gabapentin Consumption (2017-2022)
-
7.3 Europe Gabapentin Consumption (2017-2022)
-
7.4 China Gabapentin Consumption (2017-2022)
-
7.5 Japan Gabapentin Consumption (2017-2022)
-
7.6 India Gabapentin Consumption (2017-2022)
-
7.7 South Korea Gabapentin Consumption (2017-2022)
8 Region and Country-wise Gabapentin Market Analysis and Outlook to 2028
-
8.1 Global Gabapentin Consumption Forecast (2022-2028)
-
8.2 United States Gabapentin Consumption Forecast (2022-2028)
-
8.3 Europe Gabapentin Consumption Forecast (2022-2028)
-
8.4 China Gabapentin Consumption Forecast (2022-2028)
-
8.5 Japan Gabapentin Consumption Forecast (2022-2028)
-
8.6 India Gabapentin Consumption Forecast (2022-2028)
-
8.7 South Korea Gabapentin Consumption Forecast (2022-2028)
9 Global Gabapentin Market Outlook by Types and Applications to 2022
-
9.1 Global Gabapentin Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Capsule Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Tablet Consumption and Growth Rate (2017-2022)
-
9.2 Global Gabapentin Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Epilepsy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Neuropathic Pain Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Restless Legs Syndrome Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Gabapentin Market Outlook by Types and Applications to 2028
-
10.1 Global Gabapentin Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Tablet Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gabapentin Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Neuropathic Pain Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Restless Legs Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Gabapentin Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gabapentin Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gabapentin Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gabapentin Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gabapentin Market Competitive Analysis
-
14.1 Mylan
-
14.1.1 Mylan Company Details
-
14.1.2 Mylan Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Mylan Gabapentin Product and Service
-
14.2 Alkem
-
14.2.1 Alkem Company Details
-
14.2.2 Alkem Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Alkem Gabapentin Product and Service
-
14.3 Amneal
-
14.3.1 Amneal Company Details
-
14.3.2 Amneal Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amneal Gabapentin Product and Service
-
14.4 Marksans Pharma
-
14.4.1 Marksans Pharma Company Details
-
14.4.2 Marksans Pharma Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Marksans Pharma Gabapentin Product and Service
-
14.5 Intas
-
14.5.1 Intas Company Details
-
14.5.2 Intas Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Intas Gabapentin Product and Service
-
14.6 Arbor Pharma
-
14.6.1 Arbor Pharma Company Details
-
14.6.2 Arbor Pharma Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Arbor Pharma Gabapentin Product and Service
-
14.7 Apotex
-
14.7.1 Apotex Company Details
-
14.7.2 Apotex Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Apotex Gabapentin Product and Service
-
14.8 Aurobindo Pharma
-
14.8.1 Aurobindo Pharma Company Details
-
14.8.2 Aurobindo Pharma Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Aurobindo Pharma Gabapentin Product and Service
-
14.9 Jiangsu Enhua
-
14.9.1 Jiangsu Enhua Company Details
-
14.9.2 Jiangsu Enhua Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Jiangsu Enhua Gabapentin Product and Service
-
14.10 Sun Pharmaceutical
-
14.10.1 Sun Pharmaceutical Company Details
-
14.10.2 Sun Pharmaceutical Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sun Pharmaceutical Gabapentin Product and Service
-
14.11 Glenmark
-
14.11.1 Glenmark Company Details
-
14.11.2 Glenmark Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Glenmark Gabapentin Product and Service
-
14.12 TEVA
-
14.12.1 TEVA Company Details
-
14.12.2 TEVA Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 TEVA Gabapentin Product and Service
-
14.13 Sailike
-
14.13.1 Sailike Company Details
-
14.13.2 Sailike Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Sailike Gabapentin Product and Service
-
14.14 Assertio Therapeutics
-
14.14.1 Assertio Therapeutics Company Details
-
14.14.2 Assertio Therapeutics Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Assertio Therapeutics Gabapentin Product and Service
-
14.15 Jiangsu Hengrui
-
14.15.1 Jiangsu Hengrui Company Details
-
14.15.2 Jiangsu Hengrui Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Jiangsu Hengrui Gabapentin Product and Service
-
14.16 Novartis
-
14.16.1 Novartis Company Details
-
14.16.2 Novartis Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Novartis Gabapentin Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gabapentin
-
Figure Gabapentin Picture
-
Table Global Gabapentin Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gabapentin Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gabapentin Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gabapentin Consumption by Country (2017-2022)
-
Figure United States Gabapentin Consumption and Growth Rate (2017-2022)
-
Table Europe Gabapentin Consumption and Growth Rate (2017-2022)
-
Figure China Gabapentin Consumption and Growth Rate (2017-2022)
-
Figure Japan Gabapentin Consumption and Growth Rate (2017-2022)
-
Figure India Gabapentin Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gabapentin Consumption and Growth Rate (2017-2022)
-
Figure Global Gabapentin Consumption Forecast by Country (2022-2028)
-
Figure United States Gabapentin Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gabapentin Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gabapentin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gabapentin Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gabapentin Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gabapentin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Capsule Consumption and Growth Rate (2017-2022)
-
Figure Global Tablet Consumption and Growth Rate (2017-2022)
-
Figure Global Epilepsy Consumption and Growth Rate (2017-2022)
-
Figure Global Neuropathic Pain Consumption and Growth Rate (2017-2022)
-
Figure Global Restless Legs Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neuropathic Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Restless Legs Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gabapentin Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gabapentin Export by Region (Top 5 Countries) (2017-2028)
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Gabapentin Product and Service
-
Table Alkem (Foundation Year, Company Profile and etc.)
-
Table Alkem Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkem Gabapentin Product and Service
-
Table Amneal (Foundation Year, Company Profile and etc.)
-
Table Amneal Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amneal Gabapentin Product and Service
-
Table Marksans Pharma (Foundation Year, Company Profile and etc.)
-
Table Marksans Pharma Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Marksans Pharma Gabapentin Product and Service
-
Table Intas (Foundation Year, Company Profile and etc.)
-
Table Intas Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intas Gabapentin Product and Service
-
Table Arbor Pharma (Foundation Year, Company Profile and etc.)
-
Table Arbor Pharma Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arbor Pharma Gabapentin Product and Service
-
Table Apotex (Foundation Year, Company Profile and etc.)
-
Table Apotex Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Gabapentin Product and Service
-
Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)
-
Table Aurobindo Pharma Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma Gabapentin Product and Service
-
Table Jiangsu Enhua (Foundation Year, Company Profile and etc.)
-
Table Jiangsu Enhua Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangsu Enhua Gabapentin Product and Service
-
Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Gabapentin Product and Service
-
Table Glenmark (Foundation Year, Company Profile and etc.)
-
Table Glenmark Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glenmark Gabapentin Product and Service
-
Table TEVA (Foundation Year, Company Profile and etc.)
-
Table TEVA Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table TEVA Gabapentin Product and Service
-
Table Sailike (Foundation Year, Company Profile and etc.)
-
Table Sailike Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sailike Gabapentin Product and Service
-
Table Assertio Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Assertio Therapeutics Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Assertio Therapeutics Gabapentin Product and Service
-
Table Jiangsu Hengrui (Foundation Year, Company Profile and etc.)
-
Table Jiangsu Hengrui Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangsu Hengrui Gabapentin Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Gabapentin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Gabapentin Product and Service
-